- GlobeNewswire•6 days ago
NEW YORK, Sept. 23, 2016-- Stemline Therapeutics, Inc. announced today that Ivan Bergstein, M.D., Stemline’ s CEO, will present at the Ladenburg Thalmann 2016 Healthcare Conference on Tuesday, September ...
- GlobeNewswire•22 days ago
NEW YORK, Sept. 07, 2016-- Stemline Therapeutics, Inc. announced today that Ivan Bergstein, M.D., Stemline’ s CEO, will present at the Rodman & Renshaw 18 th Annual Global Investment conference on Monday, ...
- Yahoo Finance•last month
Catch The Final Round with Jen Rogers and markets correspondent Nicole Sinclair. Stocks in the green today include Stemline Therapeutics after the FDA granted Breakthrough status for its acute myeloid leukemia treatment, software maker Tableau as it appointed former Amazon exec Adam Selipsky as its new CEO, and Monsanto – shares of the seed and chemical-maker growing after Bloomberg reported Bayer and Monsanto were working on an improved takeover bid. Hillary Clinton’s presidential campaign has been dogged by accusations that wealthy Clinton Foundation donors sought favors from the State Department when Clinton was at its head.
Stemline Therapeutics, Inc. (STML)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
|Bid||10.57 x 500|
|Ask||10.68 x 400|
|Day's Range||10.55 - 11.00|
|52wk Range||3.88 - 11.29|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-4.93|
|Avg Vol (3m)||137,445|
|Dividend & Yield||N/A (N/A)|